OMEROS CORP Income Taxes Paid
OMEROS CORP (OMER) reported Income Taxes Paid of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-03-31
- OMEROS CORP income taxes paid for fiscal 2025 was $200.00K, a 0.00% change from fiscal 2024.
- OMEROS CORP income taxes paid for fiscal 2024 was $200.00K, a 93.94% decline from fiscal 2023.
- OMEROS CORP income taxes paid for fiscal 2023 was $3.30M.
| Period end | Income Taxes Paid 12 month |
|---|---|
| 2025-12-31 | $200.00K 10-K · filed 2026-03-31 |
| 2024-12-31 | $200.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $3.30M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |